Mapmygenome India Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2012PLC079091 Incorporated 10 February 2012 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company healthcare MSME · Medium
Data last updated
Revenue · FY 2025
₹31.2 Cr
▲ 2% YoY
Net profit · FY 2025
₹1.8 Cr
Net margin 5.8%
EBITDA · FY 2025
₹4.83 Cr
EBITDA margin 15.5%
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹3.44 Cr
Issued & subscribed
Open charges
₹10.19 Cr
Satisfied ₹5.69 Cr
Company age
14 yrs
Est. 2012
Employees · EPFO
87
Provident fund records

About Mapmygenome India Limited

Data last updated:

Mapmygenome India Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 10 February 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2012PLC079091. Its GSTIN is 36AAHCM7423K1Z6 (Telangana). The company holds 4 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹3.44 Cr. It is led by directors including Anuradha Acharya and Ramabadran Gopalakrishnan.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Royal Demeure Plot No. 12/2 Sector – 1 HUDA Techno Enclave Madhapur, Hyderabad, Telangana, India – 500081.

As per the financials filed for FY 2025, the company reported a revenue of ₹31.2 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.8 Cr (net margin 5.8%) and EBITDA of ₹4.83 Cr (EBITDA margin 15.5%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 30% over five years.

The company has about 87 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: MapMyGenome. As per MCA filings, the company has open charges of ₹10.19 Cr and satisfied charges of ₹5.69 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending. The company has 5 deals on record (4 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹15.59 Cr; the latest was in November 2020. Its 10 peer companies in the Healthcare industry (Diagnostics and Pathology Labs) are compared by revenue, 5 larger and 5 smaller; the largest is Health Watch Tele Diagnostics Private Limited with revenue of ₹31.83 Cr.

Mapmygenome India Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0036558). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mapmygenome.in.

Company Details of Mapmygenome India Limited
CIN U24232TG2012PLC079091
Registration Number 079091
Incorporation Date 10 February 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0036558

CIN History of Mapmygenome India Limited

Mapmygenome India has one previous CIN (Corporate Identification Number): U24232AP2012PLC079091. The current CIN is U24232TG2012PLC079091, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2012PLC079091Current
U24232AP2012PLC079091Previous

Recognitions & Rankings of Mapmygenome India

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-TS-02-0036558
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Royal Demeure Plot No. 12/2 Sector – 1 HUDA Techno Enclave Madhapur, Hyderabad, Telangana, India – 500081
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs
Comprehensive company report
Mapmygenome India Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Mapmygenome India Limited report

Financials, compliance, directors, charges, ownership and filings for Mapmygenome India Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with Mapmygenome India Limited

Mapmygenome India operates one associated brand: MapMyGenome. Each brand links to its own profile.

BrandDescriptionWebsite
Personal genetic testing and diagnostics services are provided.mapmygenome.in

Business Activity of Mapmygenome India Limited

The main business activity of Mapmygenome India is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
QHospital and Medical CareQ6Other Hospital and Medical Care ActivitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Mapmygenome India Limited FY 2025 filings available

Mapmygenome India Limited reported revenue of ₹31.2 Cr (up 2% YoY) for FY 2025.

Revenue · FY 2025
₹31.2 Cr ▲ 2%
Net profit · FY 2025
₹1.8 Cr margin 5.8%
EBITDA · FY 2025
₹4.83 Cr margin 15.5%

Compounded Annual Growth Rate (CAGR) of Mapmygenome India Limited

Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▼ 35%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 183%
3 years · compounded
▼ 26%
5 years · compounded
▲ 26%

Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 2% growth in the latest year. EBITDA rose 183% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Mapmygenome India Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹4.83 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.8 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Mapmygenome India Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin15.5%••••••••••••••••
Net Profit Margin5.8%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mapmygenome India are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Mapmygenome India Limited

Mapmygenome India has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Venkata Subash LingareddyAdditional Director14 Mar 20242 Years 7 MonthsCurrent
Anuradha AcharyaDirector20 Apr 201313 Years 6 MonthsCurrent
Ramabadran GopalakrishnanDirector01 Feb 20179 Years 8 MonthsCurrent
Arjun MalhotraDirector16 Apr 201313 Years 6 MonthsCurrent

Peer Comparison of Mapmygenome India Limited

Mapmygenome India Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Health Watch Tele Diagnostics Private Limited₹31.83 Cr (FY 2024)••••••••43.0%••••New Delhi, Delhi, India
Dr. Shaji's Mri and Medical Research Centre Private Limited₹31.75 Cr (FY 2024)••••••••0.0%••••Kozhikode, Kerala, India
Pragnashree Healthcare Private Limited₹31.66 Cr (FY 2024)••••••••6.0%••••Hyderabad, Telangana, India
Auro Mri Centre Private Limited₹31.64 Cr (FY 2025)••••••••22.0%••••Tamluk, West Bengal, India
Pankaj Scanning and Pathology Research Centre Pvt.Ltd.₹31.51 Cr (FY 2025)••••••••16.0%••••Uttar Pradesh, India
Mapmygenome India Limited this company₹31.2 Cr (FY 2025)••••••••2.0%••••Hyderabad, Telangana, India
K S K Diagnostics Private Limited₹31.07 Cr (FY 2025)••••••••39.0%••••Coimbatore, Tamil Nadu, India
Medicare Health Services Private Limited₹31.06 Cr (FY 2025)••••••••0.0%••••Srinagar, Jammu and Kashmir, India
Invicta Diagnostic Limited₹30.66 Cr (FY 2025)••••••••268.0%••••Mumbai, Maharashtra, India
Nirman Hitech Diagnostic Centre Private Limited₹30.43 Cr (FY 2025)••••••••13.0%••••Mumbai, Maharashtra, India
Eko-Diagnostic Pvt Ltd₹30.21 Cr (FY 2025)••••••••-23.0%••••Cal, West Bengal, India

Peers are the five companies nearest above and the five nearest below Mapmygenome India by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Mapmygenome India Limited

Mapmygenome India Limited is audited by P. Murali & Co for the financial year 2023.

NameStatusAppointment DateCessation Date
P. Murali & CoLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Mapmygenome India Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Mapmygenome India Limited

Open charges
₹10.19 Cr
Satisfied charges
₹5.69 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹8.00 Cr
Others₹2.17 Cr
Canara Bank₹0.02 Cr
Latest charge details
DateLenderAmountStatus
20 Dec 2023Others₹1.22 CrOpen
08 May 2023Others₹94.88 LakhOpen
13 Jan 2023Hdfc Bank Limited₹8 CrOpen
10 Oct 2022Canara Bank₹2 LakhOpen
24 Dec 2021Canara Bank₹4.15 CrSatisfied

Total charge records: 8 View all charges

Deals & Funding of Mapmygenome India Limited

Mapmygenome India Limited has 5 deals on record (4 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹15.59 Cr; the latest was in November 2020.

Total deals
5
Funding rounds
4
Convertible or debt financing
1
Disclosed funding
₹15.59 Cr

Deals on record (4 of 5)

WhenDealAmountParties
Nov 2020Funding round₹3.68 CrInvestors: 2 individuals
Dec 2019Funding round₹1.93 CrInvestors: 3 individuals
Sep 2017Funding round₹2.06 CrInvestors: RNT Capital Advisors, Singapore Angel Network, 2 individuals
Jan 2015Funding round₹2.05 CrInvestors: 3 individuals
Premium access

Full deal history

All 5 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Employees and EPFO Compliance at Mapmygenome India Limited

Mapmygenome India Limited has a workforce of 87 employees as of Apr 05, 2024.

Employee count
87
Active EPFO establishments
1
Employee growth
-35.07%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Mapmygenome India Limited

Mapmygenome India Limited has 10 board changes on record since 2013: 4 appointments and 6 cessations. The latest: Venkata Subash Lingareddy was appointed as Additional Director on 14 Mar 2024.

AGM
Mapmygenome India Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Mapmygenome India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 09 Sep 2021 via Charge ID 100480980 with Hdfc Bank Limited was fully satisfied on 06 Jun 2024.
Appointed
Venkata Subash Lingareddy was appointed as Additional Director.
Charges
A charge registered on 03 Sep 2021 via Charge ID 100477219 with Hdfc Bank Limited was fully satisfied on 18 Jan 2024.
Charges
A charge with Others amounted to Rs. 1.22 Cr with Charge ID 100854345 was registered on 20 Dec 2023.
Charges
A charge with Others amounted to Rs. 0.95 Cr with Charge ID 100736258 was registered on 08 May 2023.
Charges
A charge registered on 24 Dec 2021 via Charge ID 100555057 with Canara Bank was fully satisfied on 20 Feb 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.00 Cr with Charge ID 100680528 was registered on 13 Jan 2023.
Charges
A charge with Canara Bank amounted to Rs. 0.02 Cr with Charge ID 100640543 was registered on 10 Oct 2022.
Charges
A charge with Canara Bank of Rs. 4.15 Cr registered on 24 Dec 2021 with Charge ID 100555057 was modified on 07 Oct 2022.
Charges
A charge registered on 27 Oct 2020 via Charge ID 100405354 with Canara Bank was fully satisfied on 06 May 2022.

14 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Mapmygenome India Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Mapmygenome India Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Mapmygenome India Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Mapmygenome India Limited

Mapmygenome India has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAHCM7423K1Z6TelanganaActive01 Jul 2017
07AAHCM7423K1Z7DelhiActive01 Sep 2021
29AAHCM7423K1Z1KarnatakaActive10 Nov 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Mapmygenome India Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mapmygenome India Limited

Mapmygenome India is an active public limited company based in Hyderabad, Telangana, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 10 February 2012 (14+ years old) and is registered under CIN U24232TG2012PLC079091.

Mapmygenome India reported revenue of ₹31.2 Cr for FY 2025 (up 2% YoY).

Mapmygenome India has 4 current directors:

Mapmygenome India reported a net profit of ₹1.8 Cr (net margin 5.8%) and EBITDA of ₹4.83 Cr (EBITDA margin 15.5%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Mapmygenome India is -35% over three years and 30% over five years. In the latest year (FY 2025) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Mapmygenome India is 36AAHCM7423K1Z6, registered in Telangana. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAHCM7423K1Z7 (Delhi), 29AAHCM7423K1Z1 (Karnataka).

The CIN (Corporate Identification Number) of Mapmygenome India is U24232TG2012PLC079091. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mapmygenome India has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.

Mapmygenome India was incorporated on 10 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.

Mapmygenome India has 5 deals on record (4 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹15.59 Cr; the latest was in November 2020.

The peers of Mapmygenome India by revenue are Health Watch Tele Diagnostics Private Limited, Dr. Shaji's Mri and Medical Research Centre Private Limited, Pragnashree Healthcare Private Limited, Auro Mri Centre Private Limited, Pankaj Scanning and Pathology Research Centre Pvt.Ltd. and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available